Q3 FY2024 Earnings
Financial report interval: 2024.06.30 - 2024.09.30
Overview: Marinus Pharma(MRNS) the Revenue is 8.541 M (+16.39%);the EBIT is -21.08 M (+33.39%);the EPS is -0.423 (+30.78%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.01B16.39%
----
----
EBIT
-0.02B33.39%
----
----
EPS
-0.423330.78%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf